This project aims to develop techniques that will allow scientists to build ever larger lengths of DNA from scratch in the laboratory, with the goal of understanding better how our genomes work, and ...

CAR-T is a powerful tool which is still evolving. Here we highlight what is new in CAR-T cell therapy Cancer cells often play hide-and-seek with the immune system in an attempt to evade catastrophic ...

Why is ctDNA testing important? Traditional tissue biopsies for diagnosis can be difficult to perform and present risks to patients, particularly those who are very unwell. Up to 30,000 patients per ...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum consequat felis eu elit facilisis, sed posuere magna suscipit. Fusce urna elit, placerat quis blandit quis, mattis id ipsum. Vivamus ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel? The Regulation amounts to an ambitious and laudable step ...

Register here The first CLOCS project showed that ovarian cancer patients started buying over-the-counter medications up to 8 or 9 months before their diagnosis, with their first GP visit regarding ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

It’s been quite a wait, but the much-anticipated National Genomics Healthcare Strategy, has now landed. GENOME UK: The future of healthcare sets out plans to use genomics to drive improvements in ...

Fragment size matters Another technique that analyses non-genetic markers of cfDNA and groups them into different types – or profiles – is called fragmentomics. Fragmentomics involves looking at ...

It is no secret that the AI regulatory landscape has experienced monumental shifts in the last six months. Rhetoric that views regulation as a barrier to AI innovation and the cross-sectoral ...